LabChip® GX Touch Nucleic Acid Analyzer
The LabChip® GX Touch™ nucleic acid analyzer leverages microfluidic technology enabling DNA and RNA quantitation and sizing to be done in seconds via automated capillary electrophoresis separation.

The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Every HT protein production lab should have a couple!!!
HT Protein gels
Excellent system to QC protein samples by running 96 samples to 384 samples in one run. The data is extremely standardized and reliable with no lot-to-lot variability in the standard kit. Great after-sales care and follow-ups in case of any issues.
Review Date: 17 Mar 2023 | Revvity
It is optimal for:
- Fast, high-throughput QC analysis of NGS libraries
- NGS library preparation (smear and fragment analysis) and quality control
- RNA and DNA fragment analysis (including cell-free DNA, DNA isolated from FFPE samples, and PCR-free libraries)
- Quantitation and qualification for CRISPR fragment analysis
- Screening nucleic acid source material for vaccine development
- Characterization and QC of small RNA molecules and CRISPR/Cas9 gRNA
Accurate sizing, quantification and quality control of DNA, RNA, and NGS libraries.
The LabChip® GX Touch™ nucleic acid analyzer is a comprehensive solution for genomic sizing and quantitation. It offers:
- Quantitation of DNA and RNA sample integrity hours faster than agarose gels
- Maximize rare or low-concentration samples like cfDNA, PCR-free libraries, and ChIP-seq libraries
- Accurate quantitation down to 25 pg/µL for DNA smears and 0.5 pg/µL for fragments
- NGS library prep analysis and QC
- Flexible throughput options making it a cost-efficient – 96-well or 384-well (HT) format
- Data visualization options (electropherogram, virtual gel, or tabular report)
The LabChip GX Touch nucleic acid analyzer also supports a variety of DNA and RNA analysis, which provides unparallel genomic data quality with minimal input requirements. When the concentrations are low, and samples are precious, The LabChip® DNA High Sens and RNA Pico assays are ideal choice for reliable measurement and sample preservation. With complete analysis of genomic material in about 30 seconds, the LabChip GX Touch nucleic acid analyzer eliminates the nucleic acid quantitation workflow bottleneck. High-resolution analysis provides exact sizing and quantitation of DNA fragments and smears down to 5 bp from samples as small as 2 pg/µL.
The system offers a broad variety of DNA analysis options, including the NGS 3K assay, which provides unparalleled genomic data quality with minimal input requirements. This high degree of sensitivity also makes it the ideal instrument for gDNA and PCR-free DNA quantitation, where concentrations are low, samples are precious, and their preservation is essential.
Purity and integrity analysis of mRNA-based vaccines
By using LabChip® RNA Assay, researchers at Merck developed an assay to characterize purity and integrity of mRNA vaccines. This fast, easy and efficient workflow helped speed up vaccine development and meet increased manufacturing high volume demand.
The system offers a broad variety of DNA analysis options, including the NGS 3K assay and the cfDNA assay, which provide unparalleled genomic data quality with minimal input requirements. This high degree of sensitivity also makes it the ideal instrument for gDNA, cfDNA, and PCR-free DNA quantitation, where concentrations are low, samples are precious, and their preservation is essential.
Dimensions
- Height 69 cm | 27 in
- Width 51 cm | 20 in
- Depth 49 cm | 19.5 in
Accelerate your cell and gene therapy development
The promise of cell and gene therapies as the next generation cure for oncological and rare inherited genetic diseases is being realized. Their potential has driven a rapid expansion in both preclinical and clinical research and development.
The increasing complexity of cell and gene therapy genomic edits required to treat multifactorial diseases, and the need for precision-targeted delivery systems, is driving continual innovation aimed at expediting the availability of these life-saving treatments to patients.
This infographic provides an overview of Revvity's comprehensive cell and gene therapy solutions, emphasizing the role of innovation and automation in streamlining the therapy development workflow.


















